| Study Combining Zevalin With High-Dose Chemotherapy Prior to Autologous StemCell Transplant in Patients With Relapsed, Refractory, or Transformed Non-Hodgkin's Lymphoma (NCT00438581) | McGill University | 2007-03-01 |
| Safety and Efficacy of Bexxar Therapy in the Treatment of Relapsed/Residual B-Cell Lymphoma After Autologous Transplant (NCT00434629) | University of Pennsylvania | 2007-02-01 |
| IMPACT Non Hodgkins Lymphoma (NHL) Study (NCT00903812) | Amgen | 2007-02-01 |
| Structural Imaging and Cognitive Functions in Adult Stem Cell Transplant Recipients Treated With Chemotherapy Alone or in Combination With Radiotherapy (NCT00606216) | Memorial Sloan Kettering Cancer Center | 2007-01-01 |
| Intensification Therapy of Mature B-ALL, Burkitt and Burkitt Like and Other High Grade Non-Hodgkin's Lymphoma in Adults (NCT00797810) | University of Bologna | 2006-12-01 |
| Phase II Study of ZIO-101 in Advanced Blood and Bone Marrow Cancers (NCT00421213) | Alaunos Therapeutics | 2006-12-01 |
| A Study of ABT-263 in Subjects With Relapsed or Refractory Lymphoid Malignancies (NCT00406809) | AbbVie (prior sponsor, Abbott) | 2006-11-01 |
| A Phase I Study of Bendamustine Hydrochloride in Patients With Indolent B-cell Non-Hodgkin's Lymphoma (NCT00389051) | SymBio Pharmaceuticals | 2006-10-31 |
| MAXIMA Study: A Study of Maintenance Therapy With MabThera (Rituximab) in Patients With Non-Hodgkin's Lymphoma. (NCT00430352) | Hoffmann-La Roche | 2006-09-04 |
| Study of Psychosexual Impact of Cancer-Related Infertility in Women: Third Party Reproductive Assistance (NCT00581646) | Memorial Sloan Kettering Cancer Center | 2006-09-01 |
| Trial of VELCADE and Rituxan as Front-line Tx for Low-grade NHL (NCT00369707) | Northwestern University | 2006-08-09 |
| Allogeneic Cytokine-induced Killer Immunotherapy for Relapse After Allogeneic Marrow Transplant for Haematological Malignancies (NCT00460694) | Singapore General Hospital | 2006-08-01 |
| Study With Palonosetron Alone in Preventing Chemotherapy-induced Nausea and Vomiting in Untreated Patients With Aggressive Non Hodgkin's Lymphomas Who Underwent Moderately Emetogenic Chemotherapy (NCT01018758) | Gruppo Italiano Studio Linfomi | 2006-07-01 |
| Safety and Efficacy Study of an Anti-CD20 Monoclonal Antibody (AME-133v) to Treat Non-Hodgkin's Lymphoma (NCT00354926) | Applied Molecular Evolution | 2006-07-01 |
| Etoposide, Methylprednisolone, High-dose Cytarabine and Oxaliplatin as 2nd Line Therapy for Non-Hodgkin's Lymphoma (NHL) (NCT00336583) | Asan Medical Center | 2006-06-01 |
| An Expanded Access Program of Pegfilgrastim (Neulastim) in Participants With Non-Hodgkin's Lymphoma (NHL) (NCT02782845) | Hoffmann-La Roche | 2006-06-01 |
| Long-Term Follow-up Study for Non-Hodgkin's Lymphoma Patients Who Received Study Treatment (Plerixafor or Placebo) in the AMD3100-3101 Study (NCT00103610). (NCT00741325) | Genzyme, a Sanofi Company | 2006-06-01 |
| A Study of Dulanermin in Combination With Rituximab in Subjects With Follicular and Other Low Grade, CD20+, Non-Hodgkin's Lymphomas (NCT00400764) | Genentech, Inc. | 2006-06-01 |
| Gemcitabine for Marginal Zone Lymphoma (NCT00337259) | Asan Medical Center | 2006-06-01 |
| PROMPT - Palifermin in Reduction of Oral Mucositis in PBSC Transplantation (NCT00352703) | Swedish Orphan Biovitrum | 2006-04-01 |
| A Study of SB-743921 in Non-Hodgkin Lymphoma and Hodgkin Lymphoma (NCT00343564) | Cytokinetics | 2006-04-01 |
| Study of VELCADE and Rituximab in Patients With Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma (NCT00312845) | Millennium Pharmaceuticals, Inc. | 2006-03-01 |
| A Myeloablative Conditioning Regimen and Total Body Irradiation Followed by the Transplantation for Patients With Hematological Malignancy (NCT00597519) | Memorial Sloan Kettering Cancer Center | 2006-03-01 |
| An Extension Study Administering YM155 to Subjects Previously Enrolled in Another Protocol Administering YM155 (NCT00818480) | Astellas Pharma Inc | 2006-02-01 |
| Rituximab and CVP Plus Interferon for Follicular Non Hodgkins Lymphoma (NHL) (NCT00842114) | Fundación Leucemia y Linfoma, Spain | 2006-02-01 |
| Cytomegalovirus (CMV) Vaccine in Donors and Recipients Undergoing Allogeneic Hematopoietic Cell Transplant (HCT) (NCT00285259) | Astellas Pharma Inc | 2006-01-31 |
| Study of Immune Response Modifier in the Treatment of Hematologic Malignancies (NCT00276159) | Masonic Cancer Center, University of Minnesota | 2006-01-01 |
| Effect of Zoledronic Acid on Chemotherapy Induced Bone Loss (NCT00352846) | M.D. Anderson Cancer Center | 2006-01-01 |
| Cyclophosphamide, Doxorubicin, Vincristine, Prednisone, Rituximab Pateinets With Aggresive NHL (NCT01527422) | Fernando Cabanillas | 2006-01-01 |
| Trial of AVN-944 in Patients With Advanced Hematologic Malignancies (NCT00273936) | Vertex Pharmaceuticals Incorporated | 2006-01-01 |
| A Phase II Clinical Trial of PXD101 in Patients With Recurrent or Refractory Cutaneous and Peripheral T-Cell Lymphomas (NCT00274651) | Valerio Therapeutics | 2006-01-01 |
| Study of TPI 287 Administered Every 21 Days in Patients With Advanced Malignancies (NCT00256191) | Cortice Biosciences, Inc. | 2005-11-01 |
| Zevalin Plus BuCyE High-dose Therapy in B-cell Non-Hodgkin's Lymphoma (NCT00336843) | Asan Medical Center | 2005-11-01 |
| Trial of Outpatient Immunotherapy With Rituximab and Aldesleukin (IL-2) vs. Rituximab Alone for Non-Hodgkin's Lymphoma (NCT00250861) | US Oncology Research | 2005-10-01 |
| Safety and Efficacy of Treanda™ (Bendamustine HCl) in Patients With Indolent Non-Hodgkin's Lymphoma (NHL) Who Are Refractory to Rituximab (NCT00139841) | Cephalon | 2005-10-01 |
| A Dose and Schedule Finding Trial With AMG 531 for Chemotherapy Induced Thrombocytopenia (CIT) in Adults With Lymphoma (NCT00283439) | Amgen | 2005-10-01 |
| Safety Study of the Proteasome Inhibitor PR-171 (Carfilzomib for Injection) in Patients With Hematological Malignancies (NCT00150462) | Amgen | 2005-09-01 |
| Study of Unrelated Cord Blood Transplantation Using Tacrolimus and Sirolimus (NCT00133367) | Massachusetts General Hospital | 2005-08-01 |
| Myeloablative Umbilical Cord Blood Transplantation in Hematological Diseases (NCT00309842) | Masonic Cancer Center, University of Minnesota | 2005-07-28 |
| A Study of Induction and Maintenance Treatment With MabThera (Rituximab) in Patients With Indolent B-Cell Nonfollicular Lymphomas (NCT01153971) | Hoffmann-La Roche | 2005-07-20 |
| A Study of Ocrelizumab in Participants With Follicular Non-Hodgkin's Lymphoma (NHL) (NCT02723071) | Hoffmann-La Roche | 2005-05-01 |
| Pegylated Liposomal Doxorubicin (Doxil) With Rituximab in Relapsed AIDS-Related Non-Hodgkin's Lymphomas (NCT00183976) | University of Southern California | 2005-04-01 |
| Pegylated Liposomal Doxorubicin Containing Chemotherapy in the Treatment of Older Non-Hodgkin's Lymphoma Patients (NCT00120198) | Geriatric Oncology Consortium | 2005-03-01 |
| Study of AQ4N in Patients With Non Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia, or Small Lymphocytic Leukemia (NCT00109356) | Novacea | 2005-03-01 |
| Unrelated Donor Stem Cell Transplantation (NCT01364363) | Scripps Health | 2005-03-01 |
| Ibritumomab Tiuxetan (Zevalin)+ Rituximab Maintenance (NCT00582166) | University of Wisconsin, Madison | 2005-01-25 |
| Behavioral Intervention For BMT/SCT Survivors (NCT00579917) | Memorial Sloan Kettering Cancer Center | 2005-01-01 |
| Velcade (Bortezomib, PS-341) and Rituximab in Relapsed/Refractory Mantle Cell and Follicular Non-Hodgkin's Lymphoma (NCT00201877) | Ohio State University Comprehensive Cancer Center | 2004-12-01 |
| Rituximab, Methotrexate, Procarbazine and Vincristine Followed by High-dose Chemotherapy With Autologous Stem-cell Rescue in Newly-diagnosed Primary CNS Lymphoma (NCT00596154) | Memorial Sloan Kettering Cancer Center | 2004-12-01 |
| Safety/Tolerance Study of PPI-2458 in Subjects With Non-Hodgkin's Lymphoma and Solid Tumors (NCT00100347) | PRAECIS Pharmaceuticals Inc. | 2004-12-01 |
| Phase II Study of RT-PEPC in Relapsed Mantle Cell Lymphoma (NCT00151281) | Weill Medical College of Cornell University | 2004-11-01 |
| A Phase II Study of Clofarabine in Patients With Aggressive Non-Hodgkin's Lymphoma (NCT00201669) | Ohio State University Comprehensive Cancer Center | 2004-10-01 |
| Study: Treatment of Relapsed Lymphoid Malignancies With an Anti-Angiogenic Approach (NCT00250718) | New Mexico Cancer Research Alliance | 2004-10-01 |
| Establishing a Tumor Bank in Families With Multiple Lymphoproliferative Malignancies (NCT00131014) | Dana-Farber Cancer Institute | 2004-08-09 |
| Chemotherapy for Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma (NCT00090727) | Novacea | 2004-08-01 |
| Study for Evaluation of Efficacy and Safety of SH L 749 to Indolent B-cell Non-Hodgkin's Lymphoma (NCT00220285) | Bayer | 2004-08-01 |
| Study of Dynavax's 1018 ISS, Following Rituxan in Patients With B-Cell Follicular Lymphoma (NCT00251394) | Dana-Farber Cancer Institute | 2004-07-01 |
| Risk Adapted Therapy Optimization for Patients With Relapsed or Refractory Aggressive Non-Hodgkin-Lymphoma (NCT00384553) | University of Magdeburg | 2004-06-01 |
| Study to Evaluate the Efficacy of Rituximab in Combination With Low-dose Radiotherapy in Patients With Relapsed Non-Hodgkin's Lymphoma (NCT00147953) | University of Cologne | 2004-06-01 |
| Elsamitrucin (SPP 28090) in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma (NCT00184080) | University of Southern California | 2004-05-01 |
| Prevention of CHOP-induced Chronic Cardiotoxicity (NCT00162955) | Osaka City University | 2004-05-01 |
| A Study of Rituximab Versus Iodine I 131 Tositumomab Therapy for Patients With Non-Hodgkin's Lymphoma (NCT00078598) | Corixa Corporation | 2004-04-01 |
| SDX-105 in Combination With Rituxan for Patients With Relapsed Indolent or Mantle Cell Non-Hodgkin's Lymphoma (NHL) (NCT00076349) | Cephalon | 2004-04-01 |
| Allo-hNHL (FluBuCy) (NCT00785330) | Institut fuer anwendungsorientierte Forschung und klinische Studien GmbH | 2004-04-01 |
| Study of MGCD0103 Given Three-Times Weekly in Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma (NCT00323934) | Mirati Therapeutics Inc. | 2004-04-01 |
| CHOP and Campath-1H in Previously Untreated Aggressive T/NK-Cell Lymphomas (NCT00323323) | Ohio State University Comprehensive Cancer Center | 2004-03-01 |
| Xcellerated T CellsTM for Non-Hodgkin's Lymphoma (NHL) Patients (NCT00081783) | Xcyte Therapies | 2004-03-01 |
| Safety Study of Different Doses of hA20 (Veltuzumab) in CD20+ Non-Hodgkin's Lymphoma (NCT00596804) | Gilead Sciences | 2004-03-01 |
| Radioimmunotherapy With 90Y Zevalin for Orbital Lymphoma (NCT00387023) | M.D. Anderson Cancer Center | 2004-02-01 |
| A Study of MabThera (Rituximab) in Elderly Patients With Untreated Follicular Non-Hodgkin's Lymphoma (NHL) (NCT01144364) | Hoffmann-La Roche | 2004-01-19 |
| Phase I/II Trial of VELCADE + CHOP-Rituximab in Untreated DLCBL or Mantle Cell NHL (NCT00151320) | Weill Medical College of Cornell University | 2004-01-01 |
| Rituximab Plus CAMPATH in Patients With Relapsed/Refractory Low-Grade or Follicular, CD20-positive, B-cell NHL (NCT00077961) | Genzyme, a Sanofi Company | 2003-12-01 |
| Sirolimus With Tacrolimus for Graft-vs-Host Disease Prophylaxis After Un-Related Stem Cell Transplantation (NCT00144677) | Dana-Farber Cancer Institute | 2003-11-01 |
| Effect of Rituximab on Immunological Recall Response to Specific Antigens in the Treatment of Non-Hodgkin's Lymphoma (NCT00090038) | Biogen | 2003-10-01 |
| Safety and Activity of SDX-105 (Bendamustine) in Patients With Rituximab Refractory Non-Hodgkin's Lymphoma (NCT00069758) | Cephalon | 2003-09-01 |
| Bendamustine Plus Rituximab Versus Fludarabine Plus Rituximab (NCT01456351) | University of Giessen | 2003-09-01 |
| Rituximab Maintenance After Autologous Transplantation (NCT01103388) | M.D. Anderson Cancer Center | 2003-08-01 |
| Autologous and Allogeneic Transplant for Relapsed Lymphoma (NCT00802113) | Columbia University | 2003-06-01 |
| Amifostine for Head and Neck Irradiation in Lymphoma (NCT00136474) | Dana-Farber Cancer Institute | 2003-05-01 |
| Pegfilgrastim PBPC Mobilization Study (NCT00066092) | Amgen | 2003-04-01 |
| Cisplatin With Gemcitabine With Dexamethasone in Patients With Aggressive Non-Hodgkin's Lymphoma (NCT00491127) | Eli Lilly and Company | 2003-04-01 |
| Study of Untreated or Transformed Follicular Non-Hodgkin's Lymphoma With Fission-Derived Iodine I 131 Tositumomab (NCT00062894) | GlaxoSmithKline | 2003-04-01 |
| Safety of Interferon Gamma-1b With Rituximab in Non-Hodgkin's Lymphoma Patients (NCT00057447) | InterMune | 2003-03-01 |
| Pegfilgrastim Administered on the Same Day as Chemotherapy in Non-Hodgkin's Lymphoma (NCT00115193) | Amgen | 2003-02-01 |
| Doxorubicin (Doxil) Combined With Rituxan, Cyclophosphamide, Vincristine and Prednisone in Newly Diagnosed Aggressive Non-Hodgkin's Lymphomas (NCT00184002) | University of Southern California | 2003-01-10 |
| Immune Mobilization of Autologous Peripheral Blood Stem Cells Using Interleukin-2 and GM-CSF (NCT00952237) | Dartmouth-Hitchcock Medical Center | 2003-01-01 |
| Nonmyeloablative Allogeneic Stem Cell Transplantation From HLA-Matched Unrelated Donor for the Treatment of Hematologic Disorders (NCT00533923) | Beth Israel Deaconess Medical Center | 2002-12-01 |
| Efficacy Study of Outpatient Therapy for Lymphoma (NCT00163761) | Bayside Health | 2002-12-01 |
| Safety and Efficacy of IDEC-114 in Combination With Rituxan in the Treatment of Non-Hodgkin's Lymphoma (NCT00048555) | Biogen | 2002-11-01 |
| Phase II Study Evaluating Busulfan and Fludarabine as Preparative Therapy in Adults With Hematopoietic Disorders Undergoing MUD SCT (NCT00516152) | University of California, San Francisco | 2002-11-01 |
| INST Phase II Trial of Gemcitabine and Irinotecan in Patients With Relapsed or Refractory Lymphoma. (NCT00276003) | University of New Mexico | 2002-08-01 |
| Study of T900607-Sodium in Previously Treated Patients With Non-Hodgkin's Lymphoma. (NCT00043459) | Tularik | 2002-07-01 |
| Sirolimus With Tacrolimus for Graft-vs-Host Disease Prophylaxis After Related Stem Cell Transplantation (NCT00144703) | Dana-Farber Cancer Institute | 2002-07-01 |
| Rituxan Plus FavId (Idiotype Vaccine) for Low-grade Non-Hodgkin's Lymphoma (NCT00041730) | Favrille | 2002-07-01 |
| Treatment for Subjects With Non-Hodgkin's Lymphoma (NCT00117897) | Amgen | 2002-07-01 |
| A Study of Primary Prophylaxis With Neulasta (Pegfilgrastim) Versus Secondary Prophylaxis After Chemotherapy in Elderly Subjects (>/= 65 Years Old) With Cancer (NCT00277160) | Amgen | 2002-06-01 |
| A Study of Oral LY317615 in Relapsed or Refractory Diffuse Large B-Cell Lymphomas. (NCT00042666) | Eli Lilly and Company | 2002-06-01 |
| Safety and Efficacy of IDEC-114 in the Treatment of Non-Hodgkin's Lymphoma (NCT00575068) | Biogen | 2002-01-01 |
| Stem Cell Transplant for Hematological Malignancy (NCT00176930) | Masonic Cancer Center, University of Minnesota | 2001-10-01 |
| Nonmyeloablative Allogeneic Transplant (NCT01272817) | Scripps Health | 2001-10-01 |